Navigation Links
Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
Date:10/14/2010

l women with osteoporosis who have experienced a fracture are at increased risk for another fracture.(6,7,8)

About Prolia Prolia is approved for use in the U.S., the European Union, Canada, Australia and Switzerland. In the U.S., Prolia is approved for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.

The pivotal three-year Phase 3 Fracture REduction Evaluation of Denosumab in Osteoporosis every six Months (FREEDOM) study in 7,808 women with postmenopausal osteoporosis demonstrated that Prolia, administered as a 60mg subcutaneous injection every six months, compared with placebo at three years resulted in:

  • A 68 percent reduction in vertebral fractures (4.8 percent absolute risk reduction). The incidence of new spine fractures was 2.3 percent with Prolia vs. 7.2 percent with placebo;
  • A 40 percent reduction in hip fractures (0.3 percent absolute risk reduction). The incidence of hip fractures was 0.7 percent with Prolia vs. 1.2 percent with placebo;
  • A 20 percent reduction in non-vertebral fractures (1.5 percent absolute risk reduction). The incidence of non-spine fractures was 6.5 percent with Prolia vs. 8 percent with placebo;
  • Significant bone density increases at all key sites measured (8.8 percent at the lumbar spine, 6.4 percent at the total hip, and 5.2 percent at the femoral neck).

  • Prolia is contraindicated in patients with hypocalcemia. Pre-existing hypocalcemia must be corrected prior to initiating Prolia. Hypocalcemia may worsen, especially in patients with severe renal impairment. All patients should be adequate
    '/>"/>

    SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
    2. Array BioPharma and Amgen Partner in Type 2 Diabetes
    3. Amgen to Present at Lazard Capital Healthcare Conference
    4. Amgen Announces Webcast of 2009 Third Quarter Financial Results
    5. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
    6. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
    7. Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
    8. Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
    9. Amgen Exercises Option for Exclusive License to Cytokinetics Cardiac Contractility Program That Includes CK-1827452
    10. Amgen Announces Voting Results Of Annual Meeting Of Stockholders
    11. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
    (Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up ... many of them wrote: "Take better care of my furry companion." ... designer clothes and top-brand carrying cases to take the little canine ... might also feel compelled to buy some pricey toys at the ...
    (Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
    (Date:1/14/2014)... (PRWEB) January 14, 2014 Kerr Corporation, a ... video and additional how-to information about dual arch impressions on ... with Dual Arch Impressions,” the blog entry serves up a ... and houses a step-by-step demonstration by Dr. David Little as ...
    Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
    ... - Sales up 16% - Profit Before R&D up 19% - Net Profit (Group Share) up 12% - ... approved the 2007 consolidated financial statements:, (EUR millions) 2007 ... ... sales % change, Sales ...
    ... 12 Oncolys BioPharma,Inc. (Tokyo, Japan) and Tacere ... they have entered into a strategic alliance and,license ... interference (RNAi)-based Hepatitis C virus (HCV) compound, TT-033,code-named ... the,strategic alliance entered into by Tacere and Oncolys ...
    ... 12 Mercury Therapeutics,Inc. (MTI), a company that ... announces that it has signed an exclusive license,agreement ... Under this agreement, MTI has licensed to ... AMP-activated protein kinase (AMPK), a well,validated drug target ...
    Cached Biology Technology:STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure 2STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure 3Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 2Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 3Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences 2Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences 3
    (Date:4/24/2014)... out a welcome mat to bacteria seeking to invade, and ... published this week in the Proceedings of the National ... between microbe and host that researchers can exploit to protect ... plant Arabidopsis puts out a molecular signal that ... hostile army were unknowingly passing by a castle, and the ...
    (Date:4/23/2014)... is available in French and German . ... female? In humans and other mammals, the difference between sexes depends ... is present only in males, where the two sexual chromosomes are ... Y is ultimately responsible for all the morphological and physiological differences ... the case. A very long time ago, the X and Y ...
    (Date:4/23/2014)... Scarborough research shows that male black widow spiders prefer ... rare example of mate preference by male spiders. ... MacLeod and Maydianne Andrade, a professor in UTSC,s Department ... and the wild that males overwhelmingly chose to mate ... widows can tell whether a potential mate is well-fed ...
    Breaking Biology News(10 mins):How a plant beckons the bacteria that will do it harm 2How a plant beckons the bacteria that will do it harm 3Male or female? 2Male or female? 3Picky male black widow spiders prefer well-fed virgins 2
    ... marine clouds to cool sea surface temperatures could protect ... Research, published in Atmospheric Science Letters , proposes ... give coral a fifty year ,breathing space, to recover ... last few decades has been caused by rising sea ...
    ... in the largest continuous salt desert in the world, ... a bacterium that stores large amounts of PHB, a ... food and pharmaceutical industries, for example to produce nanospheres ... polymers to substitute for petroleum-based plastics, scientists have recently ...
    ... specialized membrane systems, made up of stacked disks linked ... (LMU) in Munich has now identified a protein that ... stack. Scanning electron microscopy (SEM) micrograph of a ... (green) and assimilation starch granules (grey). (Prepared by freeze ...
    Cached Biology News:Cloud brightening to cool seas can protect coral reefs 2Bacteria from Salar de Uyuni in Bolivia conceal bioplastic 2Photosynthesis: Membranes in tight corners 2
    ... state-of-the-art separation system using the asymmetric flow ... integrates easily with Wyatts multi-angle light scattering ... as the Optilab DSP. The combined system ... of the particles/molecules separated by the AFFF ...
    Monoclonal antibodies conjugated with rhodamine...
    ... compact and lightweight, the Moticam 2300 camera ... the eyepiece, eyetube, or trinocular port. Included ... use Plug-and-Play Images 2.0ML software offers quick ... tools to maximize resolution for examination or ...
    5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
    Biology Products: